In this multicenter, phase 3 randomized-controlled trial, researchers evaluated the efficacy and safety of SHR8028, a water-free cyclosporine solution, 0.1%, compared with vehicle in patients with dry eye...
Researchers conducted a meta-analysis to determine the global prevalence of unprescribed weight-loss product use, such as diet pills, among adolescents.
Patients with melanoma and who are being treated with PD-1 inhibitors have an increased risk of experiencing immune-related neurologic adverse events, compared with patients who are not being treated with...
The FDA approved irinotecan liposome with oxaliplatin, fluorouracil, and leucovorin as a first-line regimen for the management of patients with metastatic pancreatic adenocarcinoma.
The FDA approved the first treatment for patients with congenital thrombotic thrombocytopenic purpura (cTTP), which is a rare and life-threatening blood clotting disorder that may be fatal if left...
In a randomized clinical trial, a team of researchers compared the use of cefepime and piperacillin-tazobactam—commonly used medications for empirical treatment of infection—to determine the risks of...
This COVID-19 roundup includes coverage on the outcomes associated with two omicron subvariant treatments, FDA’s authorization of Novavax vaccine, the NIH Treatment Guidelines Panel’s recommendation of...
